Qilu Hospital of Shandong University
Jinan, Shandong, 250012, China
NCT Number: NCT07490678
Visceral Artery Aneurysm (VAA) refers to a localized or diffuse dilation or bulging of the arterial wall in the arteries supplying the gastrointestinal tract, liver, spleen, and pancreas (celiac trunk, superior mesenteric artery, inferior mesenteric artery, and their branches), caused by various pathological conditions or injuries. Among these, splenic artery aneurysms (60%) and hepatic artery aneurysms (20%) are the most common. Similar to cerebral aneurysms and aortic aneurysms, visceral artery aneurysms are a serious vascular disease that threatens human life, with an incidence of 0.2% to 2.0% in the population, second only to abdominal aortic aneurysms and iliac artery aneurysms. The main etiologies include atherosclerosis, degeneration of the arterial media, infection, fibromuscular dysplasia, congenital abnormalities, trauma, and arteritis.
The incidence of visceral artery aneurysms ranges from 0.01% to 0.20%. Although the incidence is relatively low, the rupture rate can be as high as 25%, often leading to hemorrhagic shock or even death. The treatment of VAA primarily includes open surgical procedures such as aneurysm resection and vascular reconstruction, as well as endovascular interventions such as aneurysm embolization and covered stent graft placement. Endovascular embolization is the first-line treatment for VAA. This procedure involves puncturing the femoral artery using the Seldinger technique, advancing a microcatheter near the affected vessel, injecting high-pressure iodinated contrast to visualize the lesion, and then superselecting into the aneurysm or adjacent vessels to embolize the aneurysm or its outflow tract using coils or tissue adhesive. However, X-ray-guided treatment is relatively expensive and involves complex steps. Additionally, for small aneurysms, aneurysms with narrow necks, tortuous vessels, or patients allergic to iodine, surgical resection of VAA may be the only option. Surgical procedures are associated with significant trauma, high costs, and multiple complications.
Endoscopic Ultrasound (EUS) involves an ultrasound probe attached to the tip of an endoscope, allowing imaging and fine-needle aspiration of the pancreas, gastrointestinal tract, posterior mediastinum, and retroperitoneum. Linear EUS can also identify abdominal vessels and blood flow signals via color Doppler. Therefore, after localizing the VAA with EUS, a fine-needle aspiration needle is advanced into the aneurysm. Through the needle tract, a 0.035-inch or 0.018-inch coil is deployed, and tissue adhesive is injected under direct visualization until the aneurysm is completely embolized (Figure 1). This technique has been reported in international literature.
Trial opening soon.
Get Notified18 year–60 year
All sexes
Interventional
Not applicable
Jinan, Shandong, 250012, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The patients accepted embolization of VAA via EUS
Time frame: Intraoperative and within 3 days after the embolism
The number and rate of patients with bleeding during and post-operation.
Time frame: Within 3 days after the embolism
The number and rate of patients with pancreatitis after EUS-guided VAA procedure.
Time frame: Immediately post the embolization
The rate of successful complete embolization of visceral artery aneurysm confirmed by immediate EUS evaluation after the procedure.
Time frame: Baseline
Describe the gender of the patients
Time frame: Baseline
Describe the etiology of the VAA
Contact information is provided by the study sponsor or research team.
Qilu Hospital of Shandong University
Other
The Safety and Feasibility of EUS-Guided Embolization for Visceral Artery Aneurysms: A Cohort Study
Acronym: EUS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07499206
Acute Ischemia, Aneurysm
Basel, Switzerland
View Trial DetailsNCT06507865
Acute Aortic Syndrome, Aneurysm
Vienna, Austria
View Trial DetailsNCT07704671
Aneurysm, Cardiovascular Diseases
Arnhem, Gelderland, Netherlands
View Trial DetailsNCT02638701
Aneurysm, Brain Diseases
San Francisco, California, United States
View Trial Details